Roelof Rongen
2019
In 2019, Roelof Rongen earned a total compensation of $183.3K as Former Chief Executive Officer at Matinas BioPharma Holdings, a 54% decrease compared to previous year.
Compensation breakdown
| Other | $183,333 |
|---|---|
| Total | $183,333 |
Rongen received $183.3K in other compensation, accounting for 100% of the total pay in 2019.
Rankings
In 2019, Roelof Rongen's compensation ranked 13,513th out of 13,971 executives tracked by ExecPay. In other words, Rongen earned more than 3.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,513 out of 13,971 | 3rd |
Division Manufacturing | 5,495 out of 5,692 | 4th |
Major group Chemicals And Allied Products | 2,128 out of 2,189 | 3rd |
Industry group Drugs | 1,827 out of 1,875 | 3rd |
Industry Pharmaceutical Preparations | 1,352 out of 1,387 | 3rd |
Source: SEC filing on October 1, 2020.
Rongen's colleagues
We found four more compensation records of executives who worked with Roelof Rongen at Matinas BioPharma Holdings in 2019.